Correlation Between Cognition Therapeutics and Exelixis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Exelixis, you can compare the effects of market volatilities on Cognition Therapeutics and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Exelixis.

Diversification Opportunities for Cognition Therapeutics and Exelixis

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cognition and Exelixis is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Exelixis go up and down completely randomly.

Pair Corralation between Cognition Therapeutics and Exelixis

Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the Exelixis. In addition to that, Cognition Therapeutics is 2.04 times more volatile than Exelixis. It trades about -0.24 of its total potential returns per unit of risk. Exelixis is currently generating about 0.36 per unit of volatility. If you would invest  2,873  in Exelixis on August 30, 2024 and sell it today you would earn a total of  720.00  from holding Exelixis or generate 25.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cognition Therapeutics  vs.  Exelixis

 Performance 
       Timeline  
Cognition Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cognition Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Exelixis 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Cognition Therapeutics and Exelixis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cognition Therapeutics and Exelixis

The main advantage of trading using opposite Cognition Therapeutics and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.
The idea behind Cognition Therapeutics and Exelixis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance